A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178
PHASE1CompletedINTERVENTIONAL
Enrollment
4
Participants
Timeline
Start Date
January 31, 2003
Primary Completion Date
February 28, 2003
Study Completion Date
February 28, 2003
Conditions
Metabolic Processes
Interventions
DRUG
14C-labeled YM178
oral solution (1.85 MBq)
Trial Locations (1)
9471 GP
Pharma Bio-Research Group B.V., Zuidlaren
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT01651312 - A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178 | Biotech Hunter | Biotech Hunter